Tatva Chintan Pharma Chem Ltd | Industry : (Chemicals) | |
---|---|---|
BSE Code : 543321 |
NSE Symbol : TATVA |
P/E(TTM) : 102.02 |
ISIN Demat : INE0GK401011 |
Div & Yield% : 0.20 |
EPS(TTM) : 9.67 |
Book Value(₹) : 310.31 |
Market Cap(₹Cr) : 2,307.74 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 93.81 | 93.93 | 86.07 | 92.57 | 106.11 | 119.41 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 93.81 | 93.93 | 86.07 | 92.57 | 106.11 | 119.41 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.42 | 4.53 | 1.21 | 0.76 | 1.02 | 0.78 |
Total Income | 95.23 | 98.46 | 87.28 | 93.33 | 107.12 | 120.19 |
Total Expenditure | 86.11 | 79.73 | 73.76 | 71.83 | 86.49 | 107.59 |
PBIDT | 9.12 | 18.73 | 13.52 | 21.50 | 20.63 | 12.60 |
Interest | 0.31 | 0.22 | 0.38 | 3.01 | 2.90 | 3.18 |
PBDT | 8.80 | 18.51 | 13.15 | 18.48 | 17.73 | 9.42 |
Depreciation | 6.66 | 6.23 | 6.58 | 6.78 | 6.01 | 2.53 |
Tax | 0.36 | 2.13 | 1.32 | 1.86 | 2.04 | -4.46 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.27 | 1.90 | 0.59 | 1.65 | 1.43 | -4.80 |
Reported Profit After Tax | 1.51 | 8.25 | 4.65 | 8.20 | 8.25 | 16.15 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.59 |
Adjusted Profit After Extra-ordinary item | 1.51 | 8.25 | 4.65 | 8.20 | 8.25 | 19.74 |
EPS (Unit Curr.) | 0.64 | 3.52 | 1.99 | 3.63 | 3.72 | 7.29 |
EPS (Adj) (Unit Curr.) | 0.64 | 3.52 | 1.99 | 3.63 | 3.72 | 7.29 |
Calculated EPS (Unit Curr.) | 0.64 | 3.53 | 1.99 | 3.51 | 3.72 | 7.29 |
Calculated EPS (Adj) (Unit Curr.) | 0.64 | 3.53 | 1.99 | 3.51 | 3.72 | 7.29 |
Calculated EPS (Ann.) (Unit Curr.) | 2.58 | 14.10 | 7.95 | 14.03 | 14.88 | 29.15 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.58 | 14.10 | 7.95 | 14.03 | 14.88 | 29.15 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 23.39 | 23.39 | 23.39 | 23.39 | 22.17 | 22.17 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 9.72 | 19.94 | 15.71 | 23.23 | 19.44 | 10.55 |
PBDTM(%) | 9.38 | 19.71 | 15.28 | 19.96 | 16.71 | 7.89 |
PATM(%) | 1.61 | 8.78 | 5.40 | 8.86 | 7.77 | 13.52 |